After a series of staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to ...

More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep PSA reduction higher in patients receiving Pluvicto combination vs. SoC at 12, ...

After submitting plans to cut 114 jobs tied to its U.S. headquarters in New Jersey in March, Novartis late last month added a ...

Novartis is continuing its multiyear overhaul with new plans to shutter its production facility in Wehr, Germany. | Novartis ...

Novartis (SWX:NOVN) is expanding its radioligand therapy and pharmaceutical manufacturing footprint in the US with a new ...

Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

Novartis is advancing early-stage research and clinical trials in India, reinforcing its commitment to innovative medicines ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company, announced a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure. The move ensures that all ...

FRANKFURT (Reuters) -Swiss drugmaker Novartis on Thursday forecast sales growth of 5% to 6% per year to 2030, on a currency-adjusted basis, as higher forecast peak sales for cancer drugs Kisqali and ...

Novartis is doubling down on the Triangle. The drug giant announced Thursday that it will build a 56,200-square-foot active ...

By Bhanvi Satija and Marleen Kaesebier LONDON, April 28 (Reuters) - Novartis posted first-quarter core operating profit and revenues below market expectations on Tuesday, hit by a slump in sales of ...

(Reuters) -Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for more than $70 per share, Bloomberg News reported, citing a person familiar with the matter who said an announcement ...